Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC100041430 Inhibitors

LOC100041430 can be inhibited by MAPK/ERK pathway inhibitors, such as PD98059 and U0126, work by blocking the activity of MEK, an upstream kinase, which in turn prevents the activation of ERK, a downstream effector that regulates various cellular responses. Similarly, PI3K/Akt pathway inhibitors, like LY294002, prevent the activation of Akt, a key signaling molecule involved in cell survival and growth. mTOR inhibitors, exemplified by Rapamycin, influence cellular growth and metabolism by acting on the mTOR complex, which is a central cell growth regulator.

Wnt/β-catenin pathway inhibitors, such as Wnt-C59 and XAV-939, interfere with the signaling cascade that leads to the accumulation of β-catenin in the nucleus, which affects gene transcription and cellular responses. AMPK pathway inhibitors, like Dorsomorphin, modulate energy balance within the cell by influencing AMPK, which is a sensor of cellular energy status. CDK4/6 inhibitors, such as Palbociclib, are known to halt the cell cycle by preventing the phosphorylation of retinoblastoma protein, thereby influencing cell division and proliferation.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MAPK/ERK inhibitor. Blocks MEK, which is upstream of ERK, potentially decreasing LOC100041430 activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K/Akt inhibitor. Prevents phosphorylation of Akt, possibly reducing LOC100041430 signaling.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR inhibitor. Could downregulate cellular processes influenced by LOC100041430 via mTOR pathway.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor. Modulates JNK signaling, potentially altering LOC100041430 activity if related.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAPK inhibitor. Could attenuate p38-mediated signaling affecting LOC100041430 function.

Wnt-C59

1243243-89-1sc-475634
sc-475634A
sc-475634B
5 mg
10 mg
50 mg
$210.00
$320.00
$1250.00
1
(0)

Wnt/β-catenin pathway inhibitor. Possibly influences LOC100041430 by inhibiting Wnt signaling.

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$35.00
$115.00
$515.00
26
(1)

Disrupts Wnt/β-catenin pathway. Could alter LOC100041430 function by inhibiting β-catenin.

Dorsomorphin dihydrochloride

1219168-18-9sc-361173
sc-361173A
10 mg
50 mg
$182.00
$736.00
28
(2)

AMPK inhibitor. May modulate LOC100041430's role by affecting AMPK signaling.

IWP-2

686770-61-6sc-252928
sc-252928A
5 mg
25 mg
$94.00
$286.00
27
(1)

Inhibitor of Wnt production. May reduce LOC100041430 activity by limiting Wnt ligand availability.

Palbociclib

571190-30-2sc-507366
50 mg
$315.00
(0)

CDK4/6 inhibitor. By inhibiting CDK4/6, it could indirectly affect LOC100041430's role in cell cycle.